DrugPatentWatch Database Preview
Almirall Company Profile
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
What is the competitive landscape for ALMIRALL, and what generic alternatives to ALMIRALL drugs are available?
ALMIRALL has fifteen approved drugs.
There are sixteen US patents protecting ALMIRALL drugs. There is one tentative approval on ALMIRALL drugs.
There are two hundred and eleven patent family members on ALMIRALL drugs in thirty-nine countries and seventeen supplementary protection certificates in eleven countries.
Summary for Almirall
| International Patents: | 211 |
| US Patents: | 16 |
| Tradenames: | 14 |
| Ingredients: | 12 |
| NDAs: | 15 |
| Patent Litigation for Almirall: | See patent lawsuits for Almirall |
Drugs and US Patents for Almirall
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Almirall | SEYSARA | sarecycline hydrochloride | TABLET;ORAL | 209521-001 | Oct 1, 2018 | RX | Yes | No | Start Trial | Start Trial | |||||
| Almirall | ACTICLATE | doxycycline hyclate | TABLET;ORAL | 205931-001 | Jul 25, 2014 | AB | RX | Yes | No | Start Trial | Start Trial | ||||
| Almirall | SEYSARA | sarecycline hydrochloride | TABLET;ORAL | 209521-003 | Oct 1, 2018 | RX | Yes | Yes | 8,513,223 | Start Trial | Start Trial | ||||
| Almirall | SEYSARA | sarecycline hydrochloride | TABLET;ORAL | 209521-003 | Oct 1, 2018 | RX | Yes | Yes | Start Trial | Start Trial | |||||
| Almirall | CORDRAN | flurandrenolide | OINTMENT;TOPICAL | 012806-004 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | Start Trial | Start Trial | |||||
| Almirall | CORDRAN | flurandrenolide | OINTMENT;TOPICAL | 012806-001 | Approved Prior to Jan 1, 1982 | AT | RX | Yes | Yes | Start Trial | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Almirall
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Almirall | AZELEX | azelaic acid | CREAM;TOPICAL | 020428-001 | Sep 13, 1995 | 4,386,104 | Start Trial |
| Almirall | VERDESO | desonide | AEROSOL, FOAM;TOPICAL | 021978-001 | Sep 19, 2006 | 6,730,288 | Start Trial |
| Almirall | ACZONE | dapsone | GEL;TOPICAL | 207154-001 | Feb 24, 2016 | 6,620,435 | Start Trial |
| Almirall | ACZONE | dapsone | GEL;TOPICAL | 207154-001 | Feb 24, 2016 | 5,863,560 | Start Trial |
| Almirall | XOLEGEL | ketoconazole | GEL;TOPICAL | 021946-001 | Jul 28, 2006 | 8,735,393 | Start Trial |
| Almirall | XOLEGEL | ketoconazole | GEL;TOPICAL | 021946-001 | Jul 28, 2006 | 7,179,475 | Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for ALMIRALL drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Gel | 7.5% | ➤ Subscribe | 2017-02-13 |
International Patents for Almirall Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Spain | 2371205 | Start Trial |
| Hungary | 0004040 | Start Trial |
| China | 1205211 | Start Trial |
| Japan | 2012236850 | Start Trial |
| Spain | 2701725 | Start Trial |
| European Patent Office | 3045449 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Almirall Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 1028961 | C01028961/01 | Switzerland | Start Trial | PRODUCT NAME: RETAPAMULIN; REGISTRATION NUMBER/DATE: SWISSMEDIC 58641 04.08.2009 |
| 1304992 | C01304992/01 | Switzerland | Start Trial | PRODUCT NAME: CLINDAMYCINI PHOSPHAS ET TRETINOINUM; REGISTRATION NO/DATE: SWISSMEDIC 62513 28.03.2014 |
| 1304992 | 92401 | Luxembourg | Start Trial | PRODUCT NAME: CLINDAMYCINE(EN TANT QUE PHOPSHATE DE CLINDAMYCINE)ET TRETINOINE |
| 1304992 | SPC/GB13/061 | United Kingdom | Start Trial | PRODUCT NAME: CLINDAMYCIN PHOSPHATE IN COMBINATION WITH TRETINOIN.; REGISTERED: IE PA1332/043/001 20130322; UK PL15142/0249 20130624 |
| 1304992 | CR 2013 00053 | Denmark | Start Trial | PRODUCT NAME: CLINDAMYCIN (SOM CLINDAMYCIN PHOSPHATE) OG TRETINOIN; NAT. REG. NO/DATE: 48954 20130416; FIRST REG. NO/DATE: IE PA1332/043/001 20130322 |
| 0613371 | SPC/GB02/033 | United Kingdom | Start Trial | PRODUCT NAME: FORMOTEROL (OPTIONALLY IN THE FORM OF THE FREE BASE OR A PHYSIOLOGICALLY ACCEPTABLE SALT THEREOF, OR A SOLVATE OF SUCH FREE BASE OR SALT ESPECIALLY AS FORMOTEROL FUMARATE DIHYDRATE) AND BUDESONIDE; REGISTERED: SE SE16047, 16048 20000825; UK PL17901/0091 20010515; UK PL17901/0092 20010515 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
